Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$1.04 - $2.12 $1,456 - $2,968
-1,400 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$2.11 - $2.81 $1,899 - $2,529
-900 Reduced 39.13%
1,400 $2,000
Q2 2021

Jul 19, 2021

SELL
$2.01 - $3.0 $2,210 - $3,300
-1,100 Reduced 32.35%
2,300 $3,000
Q1 2021

Apr 26, 2021

BUY
$2.09 - $5.11 $7,105 - $17,374
3,400 New
3,400 $3,000

Others Institutions Holding VCNX

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $287M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.